Professor Jane Green
BA, BM BCh, DPhil
Professor of Epidemiology
- Cancer Epidemiology Unit
- MSc in Global Health Science module 1 lead: Introduction to Global Health Science
My research focusses on identification of hormonal and other risk factors for cancer and other common and serious conditions of middle and older age in women. I am co-principal investigator for the Million Women Study, a very large cohort study of women’s health, which includes over 1.3 million UK women whose health we have followed since recruitment in 1996-2001. Major findings include increased risk of breast cancer in women using different types of hormone replacement therapy; studies of body size (obesity, height) and risk of cancer, heart disease and fractures; and assessment of the risks of long-term smoking in women. My current research includes studies of risk factors for dementia, osteoporosis and fractures, and for bowel and oesophageal cancers. I lead the Cancer Epidemiology Unit’s Cancer Screening Programmes Research Group, with studies of bowel, breast and cervical cancers, using screening programme information to investigate both the practice of screening and underlying disease mechanisms. Use of linked routinely-collected electronic health data is fundamental to our research and I am involved in several initiatives aiming to maximise the potential of such data for large-scale studies, including the UK Biobank, on whose Steering Committee I sit, and the MRC UK Dementias Research Platform.
Funding: Cancer Research UK, Medical Research Council
Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
Blanks R. et al, (2019), Int J Cancer, 145, 728 - 734
Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.
He E. et al, (2019), Int J Epidemiol, 48, 549 - 558
Cohort Profile: the Million Women Study.
Green J. et al, (2019), Int J Epidemiol, 48, 28 - 29e
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I. et al, (2018), Lancet Oncol, 19, 1680 - 1687
Differences in risk factors for 3 types of stroke: UK prospective study and meta-analyses.
Price AJ. et al, (2018), Neurology, 90, e298 - e306